In vitro assessment of cytochrome P450 inhibition and induction potential of azacitidine

被引:0
作者
Yong Chen
Lisa Liu
Eric Laille
Gondi Kumar
Sekhar Surapaneni
机构
[1] Celgene Corporation,Non
来源
Cancer Chemotherapy and Pharmacology | 2010年 / 65卷
关键词
Azacitidine; Cytochrome P450; CYP inhibition; CYP induction; Drug–drug interactions;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:995 / 1000
页数:5
相关论文
共 131 条
[1]  
Vesely J(1978)5-Azacitidine: mechanism of action and biological effects in mammalian cells Pharmacol Ther 2 813-840
[2]  
Cihak A(1985)Effects of 5-azacytidine and its 2′-deoxyderivative on cell differentiation and DNA methylation Pharmacol Ther 28 17-27
[3]  
Jones PA(2003)Gene silencing in cancer in association with promoter hypermethylation N Eng J Med 349 2042-2054
[4]  
Herman JG(2008)Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine Int J Cancer 123 8-13
[5]  
Baylin SB(2007)DNA demethylating agents and histone deacetylase inhibitors in hematologic malignancies Cancer J 13 40-48
[6]  
Stresemann C(1976)5-Azacytidine. A new anticancer drug with effectiveness in acute myelogenous leukemia Ann Intern Med 85 237-245
[7]  
Lyko F(2008)Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia Cancer 113 1596-1604
[8]  
Fandy TE(1990)Pharmacokinetic drug interactions with oral contraceptives Clin Pharmacokinet 18 472-484
[9]  
Carraway H(1996)Relevance of induction of human drug-metabolizing enzymes: pharmacological and toxicological implications Br J Clin Pharmacol 41 477-491
[10]  
Gore SD(2008)Hydroxyurea, azacitidine and gemtuzumab ozogamicin therapy in patients with previously untreated non-M3 acute myeloid leukemia and high-risk myelodysplastic syndromes in the elderly: results from a pilot trial Leuk Lymphoma 49 2141-2147